Search

everythinglearnresearchcommunity

for

Search:↓

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Biotin deficiency is not a major cause of hair loss in women, so biotin supplements are not likely to be an effective hair loss treatment.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Hair loss can be treated based on its type and cause, improving quality of life.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Baldness is often hereditary and linked to male hormones, becoming noticeable when half the hair is lost.

Androgenetic alopecia is common hair loss caused by genetics and hormones.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

A woman's scalp nodule was a common, harmless pilar cyst, treated by surgical removal.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Alternative treatments with nutrients, minerals, and vitamins are being explored for safer hair loss management.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Female pattern hair loss is common and affects quality of life, but more research is needed for better treatments.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

Common baldness can often be prevented and treated with available methods.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.